sable bio
About:
Sable Bio employs artificial intelligence to analyze large amounts of biomedical data in order to test possible drugs for toxicity.
Website: https://sablebio.com
Top Investors: Seedcamp, Episode 1, Siddhant Jayakumar
Description:
Sable Bio employs artificial intelligence to analyze large amounts of biomedical data to test possible drugs for toxicity. The data is then sent to drug developers to help them make safety judgments.
Total Funding Amount:
1.5M GBP
Headquarters Location:
London, England, United Kingdom
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-02-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai